Designing an efficient platform is crucial for any industrial process. This design process is known as process development, and it has become increasingly important in the pharmaceutical industry at ...

Drug development is an unforgiving business. Discovering a novel molecule is difficult enough, but then it can take years of preclinical studies and molecular tweaking to mitigate a drug’s toxicity, ...

Cambridge, MA – Insilico Medicine (“Insilico”), a clinical stage generative artificial intelligence (AI)-driven biotechnology company today announced a set of preclinical drug discovery benchmarks ...

Eli Lilly signs a landmark $2.75 billion deal with Insilico Medicine to harness AI for next-generation drug discovery, gaining exclusive rights to preclinical oral therapies and access to a powerful ...

Developing effective cardiovascular therapies requires robust, translational preclinical data that can reliably predict clinical outcomes. Imaging plays a central role in this process, providing ...

Genetically-humanized FcRn mice provide translational pharmacokinetics (PK) and pharmacodynamics (PD) data for antibody-based therapeutics. The image illustrates a therapeutic antibody (blue) adhering ...

Ace Therapeutics, a global leader in ophthalmic disease model development and preclinical research services, today announced its customized NHP GA model development platform focused on blue ...

The pharmaceutical industry has long operated on a one-size-fits-all model, developing drugs primarily tested on, and thus best suited for, people of European descent. This approach ignores — and ...

In this interview, Dr. John Bishop discusses the scientific and regulatory challenges of NAM adoption, where companies should ...

In 2022, the combined research and development (R&D) expenditure of the U.S. pharmaceutical industry consisted of more than $100 billion. While this is a significantly expansive market, approximately ...